News

  • February 6, 2017
    Zonisamide Endo (Zonisamide hard capsules)

    Par Laboratories Europe launches Zonisamide Endo (Zonisamide hard capsules) as monotherapy in the treatment of partial seizures, with or without secondary generalisation, in adults with newly diagnosed epilepsy or adjunctive therapy in the treatment of partial seizures, with or without secondary generalisation, in adults, adolescents, and children aged 6 years and above

  • July 17, 2016
    Strivit-D3 (Cholecalciferol 800IU Soft Capsule)

    Par Laboratories Europe launches Strivit-D3 (Cholecalciferol 800IU Soft Capsule) for the prevention and treatment of vitamin D deficiency.

  • April 4th, 2016
    Tradorec® XL (Tramadol Prolonged Release Tablets)

    Par Laboratories Europe launches Tradorec® XL for the treatment of moderate to severe pain

  • March 15th, 2016
    Generics Portfolio

    Par Laboratories Europe launches Ethambutol, Folic Acid, Mupirocin Ointment, Oxytetracycline and Tetracycline